If the 19th century was the century of chemistry and the 20th the century of physics, we believe the 21st will be the century of biology.
As we unravel secrets about DNA and deploy that knowledge to re-engineer biological systems, we believe revolutionary advances will continually transform industries from healthcare, agriculture and manufacturing to energy production, consumer services and data storage creating a historic investment opportunity. To help investors capitalize, we leveraged the insights of futurist Jamie Metzl, member of the World Health Organization’s expert committee on human genome editing, to launch a revolutionary new ETF, the WisdomTree BioRevolution Fund (WDNA).
Invest in the Power of Innovation
The biology revolution is rapidly improving our ability to understand, read, write, and hack DNA, the genetic code of all life. Learn how the WisdomTree BioRevolution Fund (WDNA) can help capitalize on this megatrend.
Jamie Metzl (WCIT 2019)
Driven by connectivity and today’s exponential advances in knowledge, science has given us the capacity to be Gods over our species. The question is, how do we we optimize the benefits and minimize the risks? Hear the fascinating facts from futurist Jamie Metzl, whose insights helped us create the new WisdomTree BioRevolution Fund (WDNA).
Are You Ready for the Genetic Revolution?
Jamie Metzl (TEDxPaloAlto)
DNA sequencing is at the core of the BioRevolution. In this thought-provoking TED Talk, renowned futurist and thought leader on the BioRevolution, Jamie Metzl, breaks down the how’s, why’s and what-if’s of the genetic revolution that is transforming this century. WisdomTree partnered with Jamie to shape the new WisdomTree BioRevolution Fund (WDNA).
Bloomberg Businessweek Podcast:
Investing in the BioRevolution Megatrend
Jeremy Schwartz, Global Head of Research at Wisdomtree and Jamie Metzl, Senior Fellow at the Atlantic Council, discuss launching their BioRevolution Fund to invest in multiple fields including vaccines, agriculture and big data analytics.
For a list of Fund holdings, visit WDNA Fund detail page.
Our BioRevolution Fund
Commentaries from Our Thought Leaders
WisdomTree has collaborated with Dr. Jamie Metzl to help create the underlying Index that the BioRevolution Fund (WDNA) seeks to track. Dr. Metzl is the author of Hacking Darwin: Genetic Engineering and the Future of Humanity and a member of the World Health Organization’s advisory committee on human genome editing. Along with our Jeremy Schwartz, he discusses the BioRevolution, WDNA and the blurring lines between science fiction and our new reality.
The intersection of biology and technology health care is driving transformations. Kara Marciscano explains how our BioRevolution Fund (WDNA) allows investors to participate in the incremental changes driving the BioRevolution on a daily basis.